These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 14585083

  • 61. Analysis of Polymorphisms rs7093069-IL-2RA, rs7138803-FAIM2, and rs1748033-PADI4 in the Group of Adolescents With Autoimmune Thyroid Diseases.
    Sawicka B, Borysewicz-Sańczyk H, Wawrusiewicz-Kurylonek N, Aversa T, Corica D, Gościk J, Krętowski A, Waśniewska M, Bossowski A.
    Front Endocrinol (Lausanne); 2020; 11():544658. PubMed ID: 33193078
    [Abstract] [Full Text] [Related]

  • 62. Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501.
    Heward JM, Allahabadia A, Sheppard MC, Barnett AH, Franklyn JA, Gough SC.
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):115-8. PubMed ID: 10468973
    [Abstract] [Full Text] [Related]

  • 63. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X, Latif R, Bahn R, Tomer Y, Davies TF.
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [Abstract] [Full Text] [Related]

  • 64. A Case Report of Conversion from Hashimoto's Thyroiditis to Graves' Disease in Type 1 Diabetic Patient Following the COVID-19 Vaccination.
    Taşkaldıran I, Altay FP, Bozkuş Y, İyidir ÖT, Nar A, Tütüncü NB.
    Endocr Metab Immune Disord Drug Targets; 2023 Nov; 23(3):405-409. PubMed ID: 35713143
    [Abstract] [Full Text] [Related]

  • 65. The role of Epstein-Barr virus infection in the development of autoimmune thyroid diseases.
    Janegova A, Janega P, Rychly B, Kuracinova K, Babal P.
    Endokrynol Pol; 2015 Nov; 66(2):132-6. PubMed ID: 25931043
    [Abstract] [Full Text] [Related]

  • 66. UCLA conference. Autoimmune thyroid diseases--Graves' and Hashimoto's.
    Ann Intern Med; 1978 Mar; 88(3):379-91. PubMed ID: 204241
    [Abstract] [Full Text] [Related]

  • 67. Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis.
    Hidaka Y, Okumura M, Shimaoka Y, Takeoka K, Tada H, Amino N.
    Thyroid; 1998 Mar; 8(3):235-9. PubMed ID: 9545110
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis.
    Okumura M, Hidaka Y, Kuroda S, Takeoka K, Tada H, Amino N.
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1757-60. PubMed ID: 9177377
    [Abstract] [Full Text] [Related]

  • 70. Evidence for thyroid antigen-reactive T lymphocytes infiltrating the thyroid gland in Graves' disease.
    Tötterman TH, Andersson LC, Häyry P.
    Clin Endocrinol (Oxf); 1979 Jul; 11(1):59-68. PubMed ID: 391444
    [Abstract] [Full Text] [Related]

  • 71. [Apoptosis in Hashimoto's thyroiditis].
    Kotani T, Aratake Y, Ohtaki S.
    Rinsho Byori; 1997 Nov; 45(11):1038-47. PubMed ID: 9396343
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
    Hashimoto K, Maruyama H, Nishiyama M, Asaba K, Ikeda Y, Takao T, Iwasaki Y, Kumon Y, Suehiro T, Tanimoto N, Mizobuchi M, Nakamura T.
    Horm Res; 2005 Nov; 64(5):253-60. PubMed ID: 16254435
    [Abstract] [Full Text] [Related]

  • 74. Fas-FasL in Hashimoto's thyroiditis.
    Stassi G, Zeuner A, Di Liberto D, Todaro M, Ricci-Vitiani L, De Maria R.
    J Clin Immunol; 2001 Jan; 21(1):19-23. PubMed ID: 11321234
    [Abstract] [Full Text] [Related]

  • 75. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers.
    Myśliwiec J, Okota M, Nikołajuk A, Górska M.
    Adv Med Sci; 2006 Jan; 51():119-22. PubMed ID: 17357290
    [Abstract] [Full Text] [Related]

  • 76. Graves' disease and Hashimoto's thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels.
    Romaldini JH, Werner MC, Rodrigues HF, Teixeira VL, Werner RS, Farah CS, Bromberg N.
    J Endocrinol Invest; 1986 Jun; 9(3):233-8. PubMed ID: 2428860
    [Abstract] [Full Text] [Related]

  • 77. Fas/FasL gene polymorphism in patients with Hashimoto's thyroiditis in Turkish population.
    Erdogan M, Kulaksizoglu M, Ganidagli S, Berdeli A.
    J Endocrinol Invest; 2017 Jan; 40(1):77-82. PubMed ID: 27572459
    [Abstract] [Full Text] [Related]

  • 78. Possible pathogenetic relevance of interleukin-1 beta in "destructive" organ-specific autoimmune disease (Hashimoto's thyroiditis).
    Paolieri F, Salmaso C, Battifora M, Montagna P, Pesce G, Bagnasco M, Richiusa P, Galluzzo A, Giordano C.
    Ann N Y Acad Sci; 1999 Jun 22; 876():221-8. PubMed ID: 10415613
    [Abstract] [Full Text] [Related]

  • 79. Expression and distribution of S-100 protein, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in thyroid tissues of autoimmune thyroid diseases.
    Xu WC, Chen SR, Huang JX, Zheng ZC, Chen LX, Lin JJ, Li YG.
    Eur J Histochem; 2007 Jun 22; 51(4):291-300. PubMed ID: 18162459
    [Abstract] [Full Text] [Related]

  • 80. The MAGI2 gene polymorphism rs2160322 is associated with Graves' disease but not with Hashimoto's thyroiditis.
    Jia X, Zhai T, Wang B, Zhang J, Zhang F.
    J Endocrinol Invest; 2019 Jul 22; 42(7):843-850. PubMed ID: 30535759
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.